Quantbot Technologies LP Purchases 244,205 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Quantbot Technologies LP lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 852.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 272,849 shares of the medical instruments supplier’s stock after purchasing an additional 244,205 shares during the quarter. Quantbot Technologies LP’s holdings in DENTSPLY SIRONA were worth $5,179,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Riverview Trust Co bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB raised its stake in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. increased its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after acquiring an additional 564 shares in the last quarter. Venturi Wealth Management LLC boosted its stake in shares of DENTSPLY SIRONA by 4,893.5% during the 3rd quarter. Venturi Wealth Management LLC now owns 2,297 shares of the medical instruments supplier’s stock worth $62,000 after acquiring an additional 2,251 shares during the last quarter. Finally, Brooklyn Investment Group bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $77,000. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $15.56 on Friday. The company’s 50-day moving average price is $18.28 and its two-hundred day moving average price is $20.93. The stock has a market cap of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA Inc. has a 52 week low of $14.77 and a 52 week high of $33.72. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. DENTSPLY SIRONA’s payout ratio is -14.07%.

Insider Activity at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.52% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on XRAY shares. Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Morgan Stanley dropped their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Finally, Evercore ISI reiterated an “in-line” rating and set a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Twelve investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.